Category - AstraZeneca

• Grievance led to threats, cyberstalk­ing, then prison
• New breast cancer drug approved by FDA
• New breast cancer drug approved by FDA
• Drug meets goals of late-stage esophagus disease trial
• Drug meets goals of late-stage esophagus disease trial
• Drug meets goals of late-stage esophagus disease trial
• Drug meets goals of late-stage esophagus disease trial
• Bad reaction
• AstraZenec­a shares fall 8.9% over merger talks with US cancer drug firm
• Bad reaction
• AstraZenec­a should stick to its winning formula. It doesn’t need a $400bn US mega-merger
• UK’s AstraZenec­a eyeing $400b merger, report says
• ‘Astra’ bid
• ‘Astra’ bid
• AstraZenec­a boss urges western drugmakers to move at ‘Chinese speed’
• DATELINE | THIS WEEK
• Attorney General Ken Paxton Secures Nearly $34 Million in Settlement Agreement with Big Pharma Company AstraZenec­a for Giving Illegal Kickbacks to Providers to Prescribe Its Drugs to Texans
• Justices spurn drug firms’ appeal of cost negotiatio­n program
• Justices spurn drug firms’ appeal of cost negotiatio­n program
• Justices reject pharma’s push to block drug price cuts
• AstraZenec­a makes surprise U-turn with £300m pharma investment in UK
• AstraZenec­a to invest $405 million in Britain
• AstraZenec­a will invest $405 million in Britain
• AstraZenec­a to invest $405 million in Britain
• AstraZenec­a to invest $405 million in Britain